Drawing for CLINICAL TRIAL PRODUCTIVITY SYSTEM

USPTO serial 99669179

CLINICAL TRIAL PRODUCTIVITY SYSTEM

Reviewed by CopyMark Law Group

Status 641Office Action
Filing date
Status date
Registration date
—
Examiner
MICHELI, ANGELA M
Law office
TMEG LAW OFFICE 101

What this means

The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.

Status 641: Status 641 means the USPTO mailed a non-final Office Action identifying issues with your application. You typically have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.

Deadline: January 1, 2027

Need help with CLINICAL TRIAL PRODUCTIVITY SYSTEM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Office Action issues

The examiner has identified that your trademark is considered descriptive, your domicile address needs to be updated to a principal place of business, your service descriptions require clarification across multiple classes, and additional fees and specimens are required.

Owner

Goods and services

ClassDescriptionStatusFirst use
035Business consulting and management in the field of clinical trials, namely, management and compilation of computerized databases in the field of clinical trials for business purposesACTIVEFeb 22, 2024
042Supporting clinical trial execution for others; Providing medical, scientific, and business intelligence research and products information in the field of clinical trials; Clinical research and process management organization services, namely, CROs, AROs, clinical trial decentralized software products, consulting services for others, in the field of program planning, execution and compliance of clinical intelligence and research that conduct clinical trials for othersACTIVEFeb 22, 2024

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 28, 2026XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Sep 28, 2026XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Jul 1, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 1, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 1, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 24, 2026DOCKASSIGNED TO EXAMINER—
Jun 23, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 25, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Feb 25, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance